BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20382349)

  • 1. Role of the immune system in hypertensive target organ damage.
    Kvakan H; Luft FC; Muller DN
    Trends Cardiovasc Med; 2009 Oct; 19(7):242-6. PubMed ID: 20382349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-related effects in hypertension and target-organ damage.
    Muller DN; Kvakan H; Luft FC
    Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):113-7. PubMed ID: 21245763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of target organ damage caused by hypertension: therapeutic potential.
    Cohuet G; Struijker-Boudier H
    Pharmacol Ther; 2006 Jul; 111(1):81-98. PubMed ID: 16288809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells ameliorate angiotensin II-induced cardiac damage.
    Kvakan H; Kleinewietfeld M; Qadri F; Park JK; Fischer R; Schwarz I; Rahn HP; Plehm R; Wellner M; Elitok S; Gratze P; Dechend R; Luft FC; Muller DN
    Circulation; 2009 Jun; 119(22):2904-12. PubMed ID: 19470887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies.
    Su DF
    Curr Opin Cardiol; 2006 Sep; 21(5):486-91. PubMed ID: 16900013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T-cells and autoimmunity.
    Ni Choileain N; Redmond HP
    J Surg Res; 2006 Jan; 130(1):124-35. PubMed ID: 16154142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
    George J
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertensive heart disease.
    Diamond JA; Phillips RA
    Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How the immune system achieves self-nonself discrimination during adaptive immunity.
    Jiang H; Chess L
    Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune mechanisms in angiotensin II-induced target-organ damage.
    Luft FC; Dechend R; Müller DN
    Ann Med; 2012 Jun; 44 Suppl 1():S49-54. PubMed ID: 22713149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of atherosclerosis and end-organ damage: a basis for antihypertensive interventional strategies.
    Schwartz CJ; Valente AJ; Hildebrandt EF
    J Hypertens Suppl; 1994 Jul; 12(5):S3-11. PubMed ID: 7965284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immune system and inflammatory diseases].
    Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2110-5. PubMed ID: 18565290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The control of anti-donor immune responses by regulatory T cells in organ transplant patients.
    Dijke IE; Weimar W; Baan CC
    Transplant Proc; 2008 Jun; 40(5):1249-52. PubMed ID: 18589082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of target organ damage in hypertension.
    Karpha M; Lip GV
    Minerva Cardioangiol; 2006 Aug; 54(4):417-29. PubMed ID: 17016413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune system: role in hypertension.
    Schiffrin EL
    Can J Cardiol; 2013 May; 29(5):543-8. PubMed ID: 22902155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of target organ damage with modern antihypertensive agents].
    Páll D; Katona E; Juhász M; Paragh G
    Orv Hetil; 2006 Aug; 147(32):1505-11. PubMed ID: 16981424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells in health and disease.
    Piccirillo CA
    Cytokine; 2008 Sep; 43(3):395-401. PubMed ID: 18722786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
    Nilsson J; Fredrikson GN; Björkbacka H; Chyu KY; Shah PK
    J Intern Med; 2009 Sep; 266(3):221-31. PubMed ID: 19702790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the immune system to treat hypertension: where are we?
    Gooch JL; Sharma AC
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):473-9. PubMed ID: 25036747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of myocardial and coronary effects of arterial hypertension].
    Strauer BE; Motz W; Vogt M
    Z Kardiol; 1989; 78 Suppl 7():231-8. PubMed ID: 2533767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.